Thursday - August 21, 2025
University of Birmingham: Innovative 'Gene-silencing' Therapy to Target Chronic Pain in Osteoarthritis
June 04, 2025
BIRMINGHAM, England, June 4 -- The University of Birmingham issued the following news:

* * *

Innovative 'gene-silencing' therapy to target chronic pain in osteoarthritis

A new peptide-siRNA drug delivery system could revolutionise treatment for osteoarthritis by targeting pain and inflammation at the source.

A new University of Birmingham-led study could pave the way for a targeted treatment for osteoarthritis (OA) that directly tackl . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products